| ［1］ |
Paus R, Cotsarelis G. The biology of hair follicles［J］. N Engl J Med, 1999,341（7）:491⁃497. doi: 10.1056/NEJM19990812341 0706.
|
| ［2］ |
Vañó⁃Galván S, Pirmez R, Hermosa⁃Gelbard A, et al. Safety of low⁃dose oral minoxidil for hair loss: a multicenter study of 1 404 patients［J］. J Am Acad Dermatol, 2021,84（6）:1644⁃1651. doi: 10.1016/j.jaad.2021.02.054.
|
| ［3］ |
Lemes LR, Melo DF, de Oliveira DS, et al. Topical and oral minoxidil for hair disorders in pediatric patients: what do we know so far?［J］. Dermatol Ther, 2020,33（6）:e13950. doi: 10. 1111/dth.13950.
|
| ［4］ |
Sinclair RD. Female pattern hair loss: a pilot study investigating combination therapy with low⁃dose oral minoxidil and spironolactone［J］. Int J Dermatol, 2018,57（1）:104⁃109. doi: 10.1111/ijd.13838.
|
| ［5］ |
Sanabria B, Vanzela TN, Miot HA, et al. Adverse effects of low⁃dose oral minoxidil for androgenetic alopecia in 435 patients［J］. J Am Acad Dermatol, 2021,84（4）:1175⁃1178. doi: 10.1016/j.jaad.2020.11.035.
|
| ［6］ |
Sharma AN, Michelle L, Juhasz M, et al. Low⁃dose oral minoxidil as treatment for non⁃scarring alopecia: a systematic review［J］. Int J Dermatol, 2020,59（8）:1013⁃1019. doi: 10.1111/ijd.14933.
|
| ［7］ |
Gupta AK, Talukder M, Venkataraman M, et al. Minoxidil: a comprehensive review［J］. J Dermatolog Treat, 2022,33（4）:1896⁃1906. doi: 10.1080/09546634.2021.1945527.
|
| ［8］ |
Olsen EA, Whiting D, Bergfeld W, et al. A multicenter, randomized, placebo⁃controlled, double⁃blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men［J］. J Am Acad Dermatol, 2007,57（5）:767⁃774. doi: 10.1016/j.jaad.2007.04.012.
|
| ［9］ |
Goren A, Shapiro J, Roberts J, et al. Clinical utility and validity of minoxidil response testing in androgenetic alopecia［J］. Dermatol Ther, 2015,28（1）:13⁃16. doi: 10.1111/dth.12164.
|
| ［10］ |
Goren A, Mccoy J, Kovacevic M, et al. The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity［J］. J Biol Regul Homeost Agents, 2018,32（4）:937⁃940.
|
| ［11］ |
Buhl AE, Waldon DJ, Kawabe TT, et al. Minoxidil stimulates mouse vibrissae follicles in organ culture［J］. J Invest Dermatol, 1989,92（3）:315⁃320. doi: 10.1111/1523⁃1747.ep12277095.
|
| ［12］ |
Goren A, Castano JA, McCoy J, et al. Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia［J］. Dermatol Ther, 2014,27（3）:171⁃173. doi: 10.1111/dth.12111.
|
| ［13］ |
Ramos PM, Goren A, Sinclair R, et al. Oral minoxidil bio⁃activation by hair follicle outer root sheath cell sulfotransferase enzymes predicts clinical efficacy in female pattern hair loss［J］. J Eur Acad Dermatol Venereol, 2020,34（1）:e40⁃e41. doi: 10.1111/jdv.15891.
|
| ［14］ |
Villani A, Fabbrocini G, Ocampo⁃Candiani J, et al. Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose［J］. J Eur Acad Dermatol Venereol, 2021,35（7）:1485⁃1492. doi: 10.1111/jdv.17216.
|
| ［15］ |
Beach RA, McDonald KA, Muylaert Barrett B. Low⁃dose oral minoxidil for treating alopecia: a 3⁃year North American retrospective case series［J］. J Am Acad Dermatol, 2021,84（3）:761⁃763. doi: 10.1016/j.jaad.2020.10.032.
|
| ［16］ |
Ramos PM, Gohad P, McCoy J, et al. Minoxidil sulfotransferase enzyme （SULT1A1） genetic variants predicts response to oral minoxidil treatment for female pattern hair loss［J］. J Eur Acad Dermatol Venereol, 2021,35（1）:e24⁃e26. doi: 10.1111/jdv.16765.
|
| ［17］ |
Pirmez R, Salas⁃Callo CI. Very⁃low⁃dose oral minoxidil in male androgenetic alopecia: a study with quantitative trichoscopic documentation［J］. J Am Acad Dermatol, 2020,82（1）:e21⁃e22. doi: 10.1016/j.jaad.2019.08.084.
|
| ［18］ |
Beach RA. Case series of oral minoxidil for androgenetic and traction alopecia: tolerability & the five C′s of oral therapy［J］. Dermatol Ther, 2018,31（6）:e12707. doi: 10.1111/dth.12707.
|
| ［19］ |
Jimenez⁃Cauhe J, Saceda⁃Corralo D, Rodrigues⁃Barata R, et al. Effectiveness and safety of low⁃dose oral minoxidil in male androgenetic alopecia［J］. J Am Acad Dermatol, 2019,81（2）:648⁃649. doi: 10.1016/j.jaad.2019.04.054.
|
| ［20］ |
Panchaprateep R, Lueangarun S. Efficacy and safety of oral minoxidil 5 mg once daily in the treatment of male patients with androgenetic alopecia: an open⁃label and global photographic assessment［J］. Dermatol Ther （Heidelb）, 2020,10（6）:1345⁃1357. doi: 10.1007/s13555⁃020⁃00448⁃x.
|
| ［21］ |
Tanaka Y, Aso T, Ono J, et al. Androgenetic alopecia treatment in Asian men［J］. J Clin Aesthet Dermatol, 2018,11（7）:32⁃35.
|
| ［22］ |
Vastarella M, Cantelli M, Patrì A, et al. Efficacy and safety of oral minoxidil in female androgenetic alopecia［J］. Dermatol Ther, 2020,33（6）:e14234. doi: 10.1111/dth.14234.
|
| ［23］ |
Rodrigues⁃Barata R, Moreno⁃Arrones OM, Saceda⁃Corralo D, et al. Low⁃dose oral minoxidil for female pattern hair loss: a unicenter descriptive study of 148 women［J］. Skin Appendage Disord, 2020,6（3）:175⁃176. doi: 10.1159/000505820.
|
| ［24］ |
Kerkemeyer KL, de Carvalho LT, Jerjen R, et al. Female pattern hair loss in men: a distinct clinical variant of androgenetic alopecia［J］. J Am Acad Dermatol, 2021,85（1）:260⁃262. doi: 10.1016/j.jaad.2020.09.042.
|
| ［25］ |
Ramos PM, Sinclair RD, Kasprzak M, et al. Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female⁃pattern hair loss: a randomized clinical trial［J］. J Am Acad Dermatol, 2020,82（1）:252⁃253. doi: 10.1016/j.jaad.2019.08.060.
|
| ［26］ |
Vahabi⁃Amlashi S, Layegh P, Kiafar B, et al. A randomized clinical trial on therapeutic effects of 0.25 mg oral minoxidil tablets on treatment of female pattern hair loss［J］. Dermatol Ther, 2021,34（6）:e15131. doi: 10.1111/dth.15131.
|
| ［27］ |
Sinclair R, Trindade de Carvalho L, Ferial Ismail F, et al. Treatment of male and female pattern hair loss with sublingual minoxidil: a retrospective case⁃series of 64 patients［J］. J Eur Acad Dermatol Venereol, 2020,34（12）:e795⁃e796. doi: 10.1111/jdv.16616.
|
| ［28］ |
Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety［J］. J Am Acad Dermatol, 2021,84（3）:737⁃746. doi: 10.1016/j.jaad.2020.06.1009.
|
| ［29］ |
Heymann WR. Coming full circle （almost）: low dose oral minoxidil for alopecia［J］. J Am Acad Dermatol, 2021,84（3）:613⁃614. doi: 10.1016/j.jaad.2020.12.053.
|
